Business Context and Reporting Period
Company: Graham Corporation
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended December 31, 1998
Business Overview: Graham Corporation manufactures products with operations in the United States and the United Kingdom. The company reported 1,584,995 shares of common stock outstanding as of February 8, 1999.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 1998 | Nine Months Ended Dec 31, 1998 |
|---|---|---|
| Net Sales | $14,219,000 | $40,792,000 |
| Net Income | $403,000 | $1,424,000 |
| Diluted EPS | $0.25 | $0.87 |
| Operating Cash Flow (9mo) | $589,000 | |
| Working Capital | $12,098,000 (as of Dec 31, 1998) | |
| Current Ratio | 2.58 (as of Dec 31, 1998) | |
| Total Debt | $1,211,000 (Short-term: $40,000; Long-term: $645,000 + Current portion: $566,000) | |
| Backlog | $17,170,000 (as of Dec 31, 1998) |
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 19% in the third quarter and 6% for the nine-month period compared to the prior year. U.S. sales rose 26% (quarter) and 8% (nine months), while U.K. sales declined 25% (quarter) and 8% (nine months).
- Profitability: Net income increased 30% in the quarter ($403k vs $309k) but decreased 16% for the nine-month period ($1.424m vs $1.687m). Diluted EPS for the nine months dropped from $1.00 to $0.87.
- Margins: Cost of sales as a percent of sales increased to 72% in the quarter (from 69%) and 71% for the nine months (from 68%), attributed to product mix and price competition. SG&A expenses as a percent of sales improved to 23% (from 27% in the prior quarter) due to insurance proceeds.
- Cash Flow: Net cash provided by operating activities for the nine months dropped significantly to $589,000 from $5,862,000 in the prior year, primarily due to decreases in operating liabilities (accounts payable and accrued compensation).
- Backlog: Total backlog decreased 45% to $17.17 million from $31.55 million a year ago, driven by a significant decline in new orders in the U.S. market.
Outlook, Risks, and Management Commentary
- Guidance: Management expects fourth-quarter sales to be below the prior year's fourth quarter due to the timing of large contract production. Cost reduction measures have been instituted to address low order levels.
- Market Conditions: Declines in new orders are attributed to weakening markets in Asia and Latin America (U.S.) and a recession in the U.K. manufacturing industry. The company is focusing on power generating and pharmaceutical markets.
- Year 2000 Readiness: The company estimates $85,000 in costs to address Y2K issues. Hardware and manufacturing software are compliant; telecommunication software remediation is expected by March 31, 1999. Risks include potential supply chain disruptions if third-party suppliers are not compliant.
- Shareholder Returns: On January 28, 1999, the Board authorized a $2 million common stock repurchase program.
- Comprehensive Income: Comprehensive income for the nine months was $547,000, significantly lower than net income due to an $867,000 minimum pension liability adjustment.
Investor Verification Checklist
- Backlog Sustainability: Verify the composition of the $17.17 million backlog and the likelihood of conversion to revenue given the 45% year-over-year decline.
- Order Intake: Monitor new order trends in the U.S. and U.K. to confirm if the shift to power and pharmaceutical markets is offsetting declines in traditional markets.
- Cash Flow Volatility: Review the significant drop in operating cash flow ($5.86m to $0.59m) to ensure liquidity remains sufficient for operations without additional financing.
- Margin Pressure: Assess the impact of severe price competition on future gross margins, which have expanded unfavorably to 71-72%.
- Y2K Contingency: Confirm the status of supplier readiness surveys and the execution of the contingency plan for third-party dependencies.